Comparative Evaluation of the Efficacy of Letrozole, L-Carnitine, and Their Combination on Sperm Quality, Oxidative Stress, and ART Outcomes in Men With Idiopathic Oligoasthenoteratozoospermia.
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Tehran University of Medical Sciences
This three-arm randomized controlled trial included 90 men with idiopathic oligoasthenoteratozoospermia (iOAT) who were assigned to receive Letrozole (2.5 mg/day), L-Carnitine (1000 mg/day), or combination therapy for 3 months. Sperm parameters, hormonal profiles, oxidative stress biomarkers, mitochondrial function, and ICSI outcomes were assessed before and after treatment.
Age
20–45
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Diagnosis of idiopathic oligoasthenoteratozoospermia (iOAT) per WHO 2021 criteria
Age 20 to 45 years
BMI between 18 and 30 kg/m²
No prior hormonal therapy or antioxidant supplements within the last 3 months
You may not be if
Varicocele, cryptorchidism, or genital tract infection